ACADIA has taken on very minimal risk with their back ended deal, why would they significantly risk and spend millions on buying out NEU with the potential of basically having it worthless if Ph.3 fails?
Or
They could propose another backended deal that also significantly reduces their exposure to a failing market by paying for positive milstones achieved. ACADIA is negotiating from a position of strength seen as they already have NA rights, management need to be willing to walk away in order to get a FRONT loaded deal.
NEU is leaky, somehow people are finding out things or 'somehow' anticiapte the correct results by either dumping or buying......IMO the SP is talking again and once again no one is listening.
- Forums
- ASX - By Stock
- NEU
- ROW Rights
NEU
neuren pharmaceuticals limited
Add to My Watchlist
3.30%
!
$15.33

ROW Rights, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$15.33 |
Change
0.490(3.30%) |
Mkt cap ! $1.907B |
Open | High | Low | Value | Volume |
$15.00 | $15.40 | $14.91 | $6.004M | 395.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 134 | $15.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.33 | 68 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 334 | 15.280 |
7 | 564 | 15.270 |
5 | 643 | 15.260 |
6 | 1116 | 15.250 |
4 | 1029 | 15.240 |
Price($) | Vol. | No. |
---|---|---|
15.300 | 1322 | 5 |
15.310 | 441 | 5 |
15.320 | 1057 | 6 |
15.330 | 1016 | 4 |
15.340 | 1056 | 4 |
Last trade - 13.25pm 18/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |